Testing

Return to HIV Research Document Library

Category Legend

Study Type(s)

Topic Area(s)

Document Type(s)

Study Method(s)

Document Method(s)

COHSONET: TB Suspect Evaluation CRF v.2 (1318)

COHSONET CRF COHSONET HIV Contact Survey Testing Community History Collection Social Positive Transmission Sample Infection Network Negative Africa Tuberculosis Epidemiology Sputum Culture Cough Diagnosis Rapid Household Environment Index Disease Symptom Clinician CXR TST International 2024 COH-Document Methods Clinical Community Health Global Health Immunology Clinical Cross Sectional Study Qual + Quant Chart Extraction Clinical

COHSONET TB suspect CRF v.2.

COHSONET: TB Suspect Evaluation CRF v.1 (1307)

COHSONET TB suspect CRF v.1.

PROBeX: Retention of Study Patients SOP (1303)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Follow-up Retention Testing Record Drug Patients Clinic ART Treatment Outreach Africa Tuberculosis Interaction Diagnosis XDR Document Visits Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Locator Registry Attendance Weekly International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX study retention SOP.

PROBeX: Sputum Collection, Transportation and Storage of Sputum Samples SOP (1302)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Testing Transportation Collection Drug Specimen Clinic ART Treatment Sample Biohazard Africa Tuberculosis Nurse Patient Sputum Culture Home Cough Diagnosis XDR Storage Field Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Breath Tube Hospital Gloves Bottle Sizwe Dinuzulu Bacterium Incubated International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX handling of sputum samples SOP.

PROBeX: Blood Sample Collection, Transportation and Processing for Intensive Pharmacokinetics Sub-study SOP (1301)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Equipment Preparation Testing Transportation Collection Drug Patients Clinic ART Treatment Africa Tuberculosis Diagnosis Blood XDR Plasma Cryovial Freezer Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling PK Sub-study Phlebotomy Cryobox Month Tubes Pharmokinetics PBMCs International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX blood sample handling for intensive PK sub-study.

PROBeX: Filing Study Related Documents SOP (1300)

PROBeX SOP TB/Coinfection Studies PROBeX Consent Eligibility HIV Screening Data Email Form Laboratory Testing Enrollment Protocol Record Drug ART Treatment Africa Tuberculosis Patient Log Diagnosis XDR Documents Ethics Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Filing Link Locator Committee Letters International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX filing study documents SOP.

PROBeX: Unscheduled Visits and Unscheduled Test Results SOP (1299)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Appointment Staff Testing Visit Results Record Drug Clinic ART Treatment Africa Tuberculosis Patient Sputum TB Diagnosis Blood XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling Hospital Unscheduled Missed International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX unscheduled visits SOP.

PROBeX: Identifying, Screening, and Enrolling Participants for Intensive PK Sub-study SOP (1298)

PROBeX SOP TB/Coinfection Studies PROBeX Consent Eligibility HIV Screening Participant Testing Criteria Enrollment Quality Record Drug Inclusion Exclusion ART Treatment Africa Tuberculosis Diagnosis XDR Document Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir PK Sub-study Intensive International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX enrollment intensive PK sub-study SOP.

PROBeX: Identifying, Screening, and Enrolling Participants SOP (1297)

PROBeX SOP TB/Coinfection Studies PROBeX Consent Eligibility HIV Screening Assistant Testing History Criteria Status Record Medical Drug Patients Inclusion Exclusion Clinic Pregnancy ART Treatment Sample Africa Tuberculosis Log Sputum Culture TB Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Family Illnesses Allergies Forms Kidney Liver International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX screening for participants SOP.

PROBeX: Site Visits and Monitoring SOP (1296)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Laboratory Participant Staff Testing Visit Site Protocol Drug Deviation Monitor Review ART Treatment Protection Subjects Report Africa Tuberculosis Patient Diagnosis XDR Storage Documents Document Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Schedule Actions International Activities Violation Debrief International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX international staff monitoring SOP.

PROBeX: Case Report Form Review SOP (1295)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Form Testing Completion Drug Lab ART Treatment Report Africa Case Tuberculosis Sputum Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Coordinator ECG International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX case report form quality SOP.

PROBeX: Blood Sample Collection, Transportation, Processing and Storage SOP (1294)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Testing Transportation Collection Safety Drug Specimen Viral ART Treatment Sample Load Africa Tuberculosis Patient CD4 Diagnosis Blood XDR Storage Plasma Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir PK Processing Pharmacogenetic Tube Hospital District International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX blood sample processing SOP.

PROBeX: Collection, Transportation and Processing for Sparse PK Sampling SOP (1293)

PROBeX SOP TB/Coinfection Studies PROBeX Consent HIV Equipment Form Laboratory Testing Transportation Collection Drug ART Treatment Africa Tuberculosis Diagnosis Blood XDR Plasma Document Cryovial Temperature Freezer Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling PK Phlebotomy Processing Cryobox Sparse Month Centrifuge Tubes Position International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX transportation and processing sparse PK sampling SOP.

PROBeX: Initial Visit SOP (1292)

PROBeX SOP TB/Coinfection Studies PROBeX Consent HIV Baseline Contact Form Interview Testing Visit Site History Enrollment Record Medical Drug Initial Privacy Demographics ART Treatment Assessment Africa Tuberculosis Patient Log Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Family International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX initial visit SOP.

PROBeX: Exit from Study SOP (1291)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Follow-up Management Study Testing Drug Exclusion Withdrawal ART Treatment Africa Tuberculosis Patient Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Exit Death Lost Decision Termination Voluntarily Absence International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX exit from study SOP.

PROBeX: Follow up Study Visits SOP (1290)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Follow-up Instructions Interview Testing Visit Collection Drug Patients Events Specimen Viral Clinic ART Treatment Sample Monthly Load Medication Africa Tuberculosis Sputum CD4 TB Diagnosis XDR Storage Plasma Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling PK Frequency Electrocardiogram Routine Logs Dosage International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Follow up visit SOP for PROBeX.

PROBeX: Obtaining Medical History SOP (1289)

PROBeX SOP TB/Coinfection Studies PROBeX Clinical HIV Information Testing History Record Medical Drug ART Treatment Africa Tuberculosis Patient Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Files Obtaining International 2020 PRO-Document Methods Clinical Chart Extraction Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

SOP for obtaining medical history PROBeX.

PROBeX: Study Reporting Plan SOP (1288)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Data Retention Study Testing Site Enrollment Monitoring Protocol Safety Plan Reporting Results Drug Distribution Specimen ART Treatment Africa Tuberculosis Diagnosis XDR Storage Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Tracking study progress SOP for PROBeX.

PROBeX: Data and Quality Management Plan SOP (1287)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Data Entry Laboratory Management Participant Testing Assurance Control Quality Plan Results Drug Review ART Treatment Report Africa Evaluation Tuberculosis Diagnosis XDR Storage Documents Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Files International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Data management SOP for PROBeX.

PROBeX: Documenting Treatment Outcomes SOP (1286)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Failure Event Testing Adverse Drug Viral Primary ART Treatment Load Africa Tuberculosis Transfer Susceptibility TB Diagnosis XDR Document Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Outcome Secondary Default Cure Completed Died Moved International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Documenting treatment outcomes SOP for PROBeX.

PROBeX: Obtaining Informed Consent SOP (1285)

PROBeX SOP TB/Coinfection Studies PROBeX Consent HIV Screening Procedure Testing Confidentiality Drug Informed Specimen ART Treatment Discussion Africa Tuberculosis Patient Sputum Diagnosis Blood XDR Storage Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Pharmacogenetic International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Obtaining informed consent SOP for PROBeX.

PROBeX: Obtaining and Reporting Clinic and Lab Assessments SOP (1284)

PROBeX SOP TB/Coinfection Studies PROBeX Counseling HIV Laboratory Research Testing Safety Test Height Weight Drug Viral Lab Clinic Pregnancy ART Treatment Report Urine Assessment Load Africa Tuberculosis Patient Sputum CD4 Diagnosis Blood XDR Storage Plasma Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Schedule X-ray Draw Electrocardiogram International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Reporting lab assessments SOP for PROBeX.

PROBeX: Collection, Transportation and Processing for Intensive PK Sampling SOP (1283)

PROBeX SOP TB/Coinfection Studies PROBeX Consent HIV Checklist Laboratory Procedure Testing Transportation Collection Drug Specimen ART Treatment Africa Tuberculosis Patient Log Diagnosis Blood XDR Plasma Freezer Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling PK Processing Intensive Pharmacokinetic Labelling Cryobox International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX collection, transportation and processing of intensive PK sampling SOP.

PROBeX: Source Documentation and Participant Source File SOP (1282)

PROBeX SOP TB/Coinfection Studies PROBeX Clinical HIV Data Information Participant Procedure Testing Results Records Drug ART Treatment Africa Source Tuberculosis Diagnosis XDR Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir File International 2020 PRO-Document Methods Clinical Chart Extraction Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Source documentation and participant source file SOP in PROBeX study.

PROBeX: Monthly Follow-up Visit CRF (1281)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Screening Management Testing Depression Weight Drug Lab Pregnant ART Treatment Sample Africa Tuberculosis Sputum CD4 Cough TB Diagnosis Blood XDR Plasma Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir X-ray Physical Lactate Fever Lymph Nodes Rash Blisters Chest Pain Muscle Diarrhea Jaundice Difficulty Joint Breath Swelling Legs Feet Numbing Hallucinations Limbs Confusion Sleeping Convulsions Seizures Fatigue Weakness Vomiting Tests Electrocardiogram Visual International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX monthly follow-up CRF.

PROBeX: Bedaquiline Treatment Completion CRF (1280)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Testing Completion Drug ART Treatment Africa Tuberculosis TB Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Bedaquiline treatment completion CRF in PROBeX study.

PROBeX: Demographics CRF (1279)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Testing Drug Demographics ART Treatment Africa Tuberculosis Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Ethnicity Gender Date Birth Race International 2020 PRO-Document Methods Quantitative Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX demographics CRF.

PROBeX: Intensive PK Sampling CRF

PROBeX CRF TB/Coinfection Studies PROBeX Administration HIV Testing History Collection Height Weight Drug Specimen ART Treatment Dose Urine Africa Tuberculosis Transport Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling Schedule PK Physical Exam Linezolid Levofloxacin Pyrazinamide Ethionamide Isoniazid Vomit Draw Hours Minutes International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Intensive PK sampling CRF for PROBeX study.

PROBeX: HIV Medication Log CRF (1277)

PROBeX TB/Coinfection Studies PROBeX HIV Testing Tracking Drug ART Treatment Dose Africa Tuberculosis Log Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Unit Frequency BD TDS Daily Name Nightly TIW QID International 2020 PRO-Document Methods Chart Extraction Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX HIV medication log CRF.

PROBeX: Sparse PK Sampling CRF (1276)

PROBeX CRF TB/Coinfection Studies PROBeX Administration HIV Testing Height Weight Drug Specimen ART Treatment Dose Urine Africa Tuberculosis Transport Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling PK Physical Exam Linezolid Levofloxacin Pyrazinamide Ethionamide Isoniazid Vomit International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PK sampling CRF for PROBeX study.

PROBeX: TB Medication Log CRF (1275)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Testing Tracking Drug ART Treatment Dose Africa Tuberculosis Log TB Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Unit Frequency BD TDS Daily Name Nightly TIW QID International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX TB medication log CRF.

PROBeX: Study Exit CRF (1274)

PROBeX CRF TB/Coinfection Studies PROBeX Consent HIV Contact Testing Drug Withdraw ART Treatment Africa Tuberculosis Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Exit Final Reason Death Lost International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX participant exit CRF

PROBeX: Blood Results Eligibility Confirmation CRF (1273)

PROBeX CRF TB/Coinfection Studies PROBeX Eligibility HIV Testing Collection Results Drug Specimen ART Treatment Africa Tuberculosis Diagnosis Blood XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Creatinine ALT Bilirubin Haemoglobin FBC Platelets Chemistry Potassium Albumin ALP TSH Lactate International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX study eligibility from blood results CRF.

PROBeX: Eligibility Conformation CRF (1272)

PROBeX CRF TB/Coinfection Studies PROBeX Eligibility HIV Testing Criteria Enrollment Drug Inclusion Exclusion ART Treatment Africa Tuberculosis Age Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Extra-pulmonary Creatinine Serum ALT Bilirubin International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Inclusion and exclusion criteria CRF for PROBeX study.

PROBeX: Sputum Results Eligibility Confirmation CRF (1271)

PROBeX CRF TB/Coinfection Studies PROBeX Eligibility HIV Testing Collection Results Drug Specimen ART Treatment Africa Tuberculosis Sputum Culture Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Isoniazid Assay PCR Injectables Rifampicin Kanamycin Streptomycin Fluoroquinolones Amikacin Capreomycin Moxifloxacin Confirmation Ofloxacin International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

CRF for sputum lab in PROBeX study.

PROBeX: Sputum Labs CRF (1270)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Testing Collection Results Drug Molecular Specimen ART Treatment Sample Africa Tuberculosis Sputum Smear Culture DST Diagnosis XDR Labratory Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Isoniazid Assay PCR Injectables Rifampicin Kanamycin Streptomycin Oflozacin Fluoroquinolones Amikacin Capreomycin Moxifloxacin Clodazimine Phenotypic International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

CRF for sputum lab in PROBeX study.

PROBeX: Intensive PK Sampling Follow-up Visit CRF (1269)

PK sampling follow-up CRF for PROBeX study.

PROBeX: Initial Visit CRF (1268)

PROBeX CRF TB/Coinfection Studies PROBeX HIV Management Research Testing Visit History Risk Drug Alcohol Initial ART Treatment Facility Regimen Africa Tuberculosis Sputum TB Symptoms Diagnosis ARV Blood XDR Samples Healthcare Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Outcome Prison Mines Household Hospitalized X-ray International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Participant intake history form for PROBeX study.

PROBeX: Protocol (1267)

PROBeX Consent Forms TB/Coinfection Studies PROBeX Consent HIV Screening Data Procedure Recruitment Testing Analysis Benefits Monitoring Protocol Risks Confidentiality Timeline Drug Informed Viral Clinic ART Antiretroviral Treatment Urine Load Africa Tuberculosis Mortality Hospitals Sputum CD4 Diagnosis Blood Storage Plasma Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Global FDA Inhibitor Transmissions Genome Sequencing Therapy Pharmacodynamics Schedule Pharmacogenetics PK Sub-study Phlebotomy Populations Vulnerable International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Protocol for PROBeX study.

PROBeX: Participant Informed Consent Form

PROBeX Consent Forms TB/Coinfection Studies PROBeX Consent HIV Testing Confidentiality Questionnaire Drug Informed Specimen ART Treatment Urine Africa Tuberculosis Sputum Diagnosis Blood XDR Storage Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling Hair International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX study participant informed consent form.

PROBeX: Information Sheet (1265)

PROBeX Recruitment Materials TB/Coinfection Studies PROBeX HIV Contact Information Study Testing Benefits Risks Drug ART Treatment Africa Tuberculosis Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sheet Description Involvement Time International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX study participant information sheet.

PROBeX: Screening Consent Form (1263)

PROBeX Consent Forms TB/Coinfection Studies PROBeX Eligibility HIV Screening Testing Drug Chart Extraction ART Treatment Africa Tuberculosis Diagnosis XDR Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX participant screening consent form.

PROBeX: Participant Informed Consent Form inc. Hair Sample (1262)

PROBeX Consent Forms TB/Coinfection Studies PROBeX Consent HIV Testing Confidentiality Questionnaire Drug Informed Specimen ART Treatment Urine Africa Tuberculosis Sputum Diagnosis Blood XDR Storage Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX participant informed consent form including hair sample.

PROBeX: Participant Consent Form (1261)

PROBeX Consent Forms TB/Coinfection Studies PROBeX Consent HIV Participation Research Study Testing Risks Drug Informed ART Treatment Africa Cost Tuberculosis Diagnosis XDR Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study

PROBeX study participant consent form.

TRAX: Parent or Legal Guardian Informed Consent Form (1260)

TRAX Consent Forms TRAX TB/Coinfection Studies Consent Contact Information Testing Community Resource Benefits Collection Procedures Risks Confidentiality Social Rural Drug Informed Intervention Transmission Network Africa Cluster Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings Sputum TB Blood XDR Children Parent Guardian International 2014 Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

Parent or legal guardian informed consent form for children participating in TRAX study.

TRAX: Adolescent Assent Form (1259)

TRAX Consent Forms TRAX TB/Coinfection Studies Contact Form Participant Testing Community Resource Social Questions Rural Drug Intervention Transmission Network Africa Cluster Adolescent Assent Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings TB XDR Children Choice Minor Witness International 2014 Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

TRAX study participants 7 years or older assent form.

TRAX: Adult Informed Consent Form (1258)

TRAX Consent Forms TRAX TB/Coinfection Studies Consent Contact Form Information Participation Research Testing Community Resource Benefits Collection Risks Participants Confidentiality Social Rural Drug Informed Intervention Specimen Adult Transmission Future Network Africa Cluster Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings TB XDR Voluntary International 2014 Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

TRAX study adult participant informed consent form.

TRAX: Protocol (1257)

TRAX Protocols TRAX TB/Coinfection Studies Consent Contact Study Testing Community Resource Background Design Procedures Statistics Risk Social Rural Drug Process Intervention Transmission Network Africa Cluster Rationale Considerations Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings Measures Compliance Benefit Evaluations International 2014 Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

Post-exposure protocol for TRAX study staff.

TRAX: Needle Stick Injury and HIV Post Exposure SOP (1256)

TRAX SOP TRAX TB/Coinfection Studies HIV Contact Testing Community Resource Safety Social Rural Drug Intervention Viral Clinic Transmission Infection Network Medication Africa Cluster Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings Exposure Needle Injury Sharps Fluids Splash Prophylaxis PEP Hepatitis International 2014 TRAX-Document Methods Clinical Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

Post exposure protocol for TRAX study staff.

TRAX: Source Documentation SOP (1255)

TRAX SOP TRAX TB/Coinfection Studies Contact Data Form Testing Community Resource Records Social Questionnaire Rural Drug Intervention DAIDS Transmission Network Africa Cluster Source Tracing Resistant Genotype Tuberculosis Mortality Patterns Epidemiology Limited Co-infection South Hospitals Immunocompromised Congregate Interaction Settings Documentation International 2014 TRAX-Document Methods Chart Extraction Clinical Prevention Community Health Behavioral Health Equity Virology Genetics Clinical Cross Sectional Study Clinical Chart Extraction Qualitative

Source documentation protocol for TRAX study staff.